INSILICO (03696) has been included in the MSCI Global Small Cap Index.

date
08:26 17/08/2026
avatar
GMT Eight
InSilicon (03696) announced that it will be included in the MSCI Global Small Cap Index, which aims to reflect the performance of small-cap companies across various diversified sectors in both developed and emerging markets. This inclusion will take effect after the market closes on Monday, August 31, 2026.
INSILICO (03696) announced that it will be included in the MSCI (Morgan Stanley Capital International) Global Small Cap Index, which aims to reflect the performance of small-cap companies across various diversified sectors in both developed and emerging markets. This inclusion will take effect after the market closes on August 31, 2026 (Monday). Since its listing on the Hong Kong Stock Exchange, INSILICO has been successively included in several major index series, including the CSI Index series (CSI Hong Kong Stock Connect Innovative Drug Index, CSI Hong Kong Innovative Drug Index, and CSI Hong Kong Stock Connect Healthcare Comprehensive Index), the Hang Seng Composite Index, the Hang Seng Healthcare Index, the Hang Seng Biotech Index, the FTSE Global Small Cap Index, the FTSE All-World Index, and the FTSE Global Total Market Index. The Board believes that the company's recent inclusion in the MSCI Global Small Cap Index reflects the growing recognition by the capital markets of the companys core competitive advantages, scalable business model, and significant commercial potential. This inclusion is expected to enhance the company's visibility among international institutional investors and research analysts, attract passive fund inflows tracking the relevant indices, diversify the shareholder base, and improve the trading liquidity of its shares.